Literature DB >> 2580858

Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure.

J R Wilkins, A J D'Ercole.   

Abstract

By using disuccinimidyl suberate, we have covalently cross-linked 125I-labeled somatomedin-C (Sm-C)/insulinlike growth factor I to specific binding proteins in human plasma. In unfractionated plasma samples from normal and acromegalic donors, 125I-Sm-C binding-protein complexes with relative molecular weights (Mr) of 160,000, 135,000, 110,000, 80,000, 50,000, 43,000-35,000, and 28,000-24,000 were consistently observed. In contrast, the 43,000-35,000-mol wt species were frequently the only specific complexes observed in hypopituitary plasma and were consistently more intensely labeled in such samples. Reduction of samples with beta-mercaptoethanol did not alter the electrophoretic pattern of these 125I-Sm-C binding-protein complexes. All Sm-C binding proteins, with the exception of the 43,000-35,000-mol wt complex, were adsorbed by concanavalin A-Sepharose. When acromegalic or normal plasma was fractionated on a Sephadex G-200 column and affinity labeled, the same complexes that were adsorbed by concanavalin A were found in fractions that eluted near the gamma-globulin peak. On the other hand, the 43,000-35,000-mol wt complex consistently eluted in size-appropriate fractions near the albumin peak. These data suggest that the growth hormone (GH)-dependent Sm-C binding protein, represented by the 160,000-mol wt complex, is in some way composed of smaller species, i.e., the 135,000-, 110,000-, 80,000-, 50,000-, and 28,000-24,000-mol wt complexes. Acid incubation of plasma prior to Sephadex G-200 chromatography results in the elimination of specific 125I-Sm-C binding-protein complexes which elute near gamma-globulin and a concurrent increase in the labeling intensity of the 28,000-24,000-mol wt complexes. We speculate, therefore, that each of the GH-dependent Sm-C binding-protein complexes represents an oligomer composed of 28,000-24,000-mol wt protomers. The 43,000-35,000-mol wt species is not dependent upon GH and appears to represent a different type of Sm-C binding protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580858      PMCID: PMC425465          DOI: 10.1172/JCI111836

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein.

Authors:  J Zapf; M Waldvogel; E R Froesch
Journal:  Arch Biochem Biophys       Date:  1975-06       Impact factor: 4.013

3.  Specific binding of a somatomedin-like polypeptide in rat serum depends on growth hormone.

Authors:  A C Moses; S P Nessley; K L Cohen; M M Rechler
Journal:  Nature       Date:  1976-09-09       Impact factor: 49.962

4.  Demonstration of specific plasma protein binding sites for somatomedin.

Authors:  R L Hintz; F Liu
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

5.  Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins.

Authors:  G E Davies; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Chemical cross-linking: reagents and problems in studies of membrane structure.

Authors:  K Peters; F M Richards
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

8.  Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.

Authors:  U Kaufmann; J Zapf; B Torretti; E R Froesch
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

9.  The serum half-life of somatomedin activity: evidence for growth hormone dependence.

Authors:  K L Cohen; S P Nissley
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

10.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

Authors:  E Rinderknecht; R E Humbel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

View more
  18 in total

1.  Somatomedin C deficiency in Asian sisters.

Authors:  M E McGraw; D A Price; D J Hill
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

Review 2.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

3.  Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.

Authors:  D R Clemmons; R G Elgin; V K Han; S J Casella; A J D'Ercole; J J Van Wyk
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Insulin-like growth factor-binding protein PP12 in ovarian cyst fluid.

Authors:  M Seppälä; G Than
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 5.  Somatomedin-binding proteins: what role do they play in the growth process?

Authors:  S Cianfarani; J M Holly
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

6.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling.

Authors:  R C Baxter; J L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation.

Authors:  C A Conover; F Liu; D Powell; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Alteration in IGF-I binding in the cerebral cortex and cerebellum of neonatal rats during protein-calorie malnutrition.

Authors:  H G Maheshwari; S Mermelstein; A S vonSchlegell; G E Shambaugh
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

9.  Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; C Schmid; H P Guler; M Waldvogel; C Hauri; E Futo; P Hossenlopp; M Binoux; E R Froesch
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

10.  Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.

Authors:  H J Cornell; G Enberg; A C Herington
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.